Cortex Pharmaceuticals (COR): Q4 EPS of $0.34 beats by $0.01. Revenue of $46M (+19.8% Y/Y)...

|By:, SA News Editor
Cortex Pharmaceuticals (COR): Q4 EPS of $0.34 beats by $0.01. Revenue of $46M (+19.8% Y/Y) in-line. (PR)